HCi VioCare  

(Public, OTCMKTS:VICA)   Watch this stock  
0.000 (0.00%)
May 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.08 - 2.00
Open     -
Vol / Avg. 0.00/35,726.00
Mkt cap 39.01M
P/E     -
Div/yield     -
EPS -0.01
Shares 195.06M
Beta -0.01
Inst. own     -

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -1082.51% -232.19%
Operating margin -1076.65% -233.55%
EBITD margin - -223.71%
Return on average assets -327.84% -416.37%
Return on average equity - -
CDP Score - -


Kintyre Hse, 209 Govan Road
United Kingdom - Map
+44-141-3700321 (Phone)

Website links


HCi Viocare, formerly China Northern Medical Device, Inc., is a start-up enterprise. The Company is engaged in the research and development and marketing of medical technologies, and the operation of prosthetics and orthotics (P&O) and diabetic foot total rehabilitation clinics. It is also engaged in the technology development and licensing of bioengineering innovations for the health, sports and wellness sectors. It was formed to sell medical devices with an emphasis on portable medical devices designed for home treatments with the initial focus in the northern regions of China. It intends to seek strategic relationships with medical device manufacturers both in China and North America with the aim to be their sales and distribution agent in Northern China and to assist Chinese medical device manufacturers on the development of the North American market. Its subsidiaries include HCi Viocare Technologies Limited, HCi Viocare Clinics UK Limited and HCi Viocare Clinics (Hellas) S.A.

Officers and directors

Sotirios Leontaritis Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Age: 54
Nicolaos Kardaras Secretary, Director
Age: 64
Christos Kapatos Director
Age: 37
Yannis Levantis Director